(Q27627151)

2

0 references

J Cheng

3

0 references

W R Roush

4

0 references

J H McKerrow

5

0 references

R J Fletterick

The proteases and pathogenicity of parasitic protozoa

6

0 references

publication date

15 August 2000

0 references

published in

Structure

0 references

volume

8

0 references

issue

8

0 references

page(s)

831-40

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Cysteine Proteases and Their Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Reversible binding of peptide aldehydes to papain. Structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Engineering nitrile hydratase activity into a cysteine protease by a single mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Structural determinants of specificity in the cysteine protease cruzain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

The crystal structure of cruzain: a therapeutic target for Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Design of potent and selective human cathepsin K inhibitors that span the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Crystal structure of human cathepsin K complexed with a potent inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Vinylogous amino acid esters: a new class of inactivators for thiol proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Vinyl sulfones as mechanism-based cysteine protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

The lysosomal cysteine proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Anatomy of hot spots in protein interfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Isolation and quantification of fluoroacetate in rat tissues, following dosing of Z-Phe-Ala-CH2-F, a peptidyl fluoromethyl ketone protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Theoretical and practical aspects of proteinase inhibition kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

AMoRe: an automated package for molecular replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Crystallographic R factor refinement by molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

An extensively modified version of MolScript that includes greatly enhanced coloring capabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2800%2900173-8

7 January 2021